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clinically characterised late onset Alzheimer's disease (LOAD) by the. This is an open access article underInstitute of GenomicMedicine and Rare Disorders, Semmelweis Univer-
sity, Budapest (Hungary).
To generate the BIOT-0904-LOAD iPSC line (Fig. 1A) the four
“Yamanaka reprogramming factors” OCT3/4, SOX2, KLF4, and C-MYC
were delivered into PBMCs using the integration-free Sendai virus
gene-delivery method (Yang et al., 2008; Fusaki et al., 2009). The
iPSC-like colonies were picked after 20–27 days post-transduction. Be-
ginning from passage 5 of the iPSCs the absence/presence of Sendai
virus vector was analysed by RT-PCR using Sendai virus vector (SeV) -
speciﬁc primers (Table 1). After 7 passages, the elimination of the
reprogramming vector was conﬁrmed in BIOT-0904-LOAD iPSC line
which was selected for further analysis (Fig. 1B).
The karyotype of the BIOT-0904-LOAD iPSC line was determined
with Giemsa-banding, proving normal diploid 46, XX karyotype, with-
out any detectable abnormalities (Fig. 1B).
Expression of pluripotencymarkers was examined by immunocyto-
chemistry staining, using antibodies against human OCT3/4, E-
CADHERIN, and NANOG (Fig. 1A). The in vitro spontaneous differentia-
tion potential towards the three germ layer of the BIOT-0904-LOAD
iPSC line was demonstrated by the expression of ectodermal (βIII-TU-
BULIN), mesodermal (BRACHYURY) and endodermal (GATA4) markers
(Fig. 1A) (Itskovitz-Eldor et al., 2000; Carpenter et al., 2003).
Materials and methods
Reprogramming of peripheral blood mononuclear cells (PBMC)
PBMCs were isolated within 2 h post-collection using the
Vacutainer® CPT™ Cell Preparation Tube with Sodium Heparin, (BD
Biosciences) and separated by centrifugation (1800 rcf, 30 min, room
temperature (RT). The freshly isolated PBMCs were seeded (0.5 × 106the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Characterisation of BIOT-0904-LOAD hiPSC line. A) Above: Morphology of generated hiPSCs (4×) and representative immunoﬂuorescent micrographs of iPSCs positive for
stem cells markers OCT3/4, NANOG and E-CADHERIN (in green). Alkaline phosphatase (AP) activity was also detected in iPSCs. Below: Spontaneously formed EBs in suspension
culture (Day 5) and after attachment and further differentiation (Day 14). Immunostainings for endodermal (GATA4), mesodermal (BRACHYURY) and ectodermal (βIII-
TUBULIN) germ layers, markers (in green). Nucleus is labelled with DAPI (in blue). B) RT-PCR veriﬁcation of the absence of Sendai-virus from the reprogrammed cells and
karyogram showing normal 46 chromosomes (XX).
82 Z. Táncos et al. / Stem Cell Research 17 (2016) 81–83cells) in Expansion Medium (EM): QBSF-60 medium (Quality Biologi-
cal) supplemented with 50 μg/ml Ascorbic acid, 1% Penicillin/Strepto-
mycin, 50 ng/ml SCF (R&D systems), 10 ng/ml IL-3 (R&D systems),
2 U/ml EPO (R&D systems), 40 ng/ml IGF-1 (R&D systems) and 1 μM
Dexamethasone. Nine days later (Day 0) the cells were transduced by
Sendai-virus delivery using the CytoTune®-iPS 2.0 Sendai
Reprogramming Kit (Thermo Fisher Scientiﬁc), following the
manufacturer's instruction. Brieﬂy, the cells were transduced on 1 w/
24 wp in 1 ml EM supplemented with 4 μg polybrene. The calculated
volumes of each of the three CytoTune™ 2.0 Sendai-virus (SeV) was
added to the cells using MOI of 5-5-3 (KOS MOI = 5, hc-Myc MOI =
5, hKlf4 MOI = 3). The cell containing plate was centrifuged (900 rcf,
90min, RT) and incubated for 24 h. The following day the cells were col-
lected, centrifuged (300 rcf, 5 min, RT) and seeded in fresh EM (Day 1).
Two days later (Day 3) the cells were passed onto a 6 cm dish covered
with 0.1% gelatin and 0.65 × 106 Mitomycin C treated-MEF in QBSF-60
medium (Quality Biological) supplemented with 50 μg/ml Ascorbic
acid. Seven days post-transduction (Day 7) the medium was replaced
with HESC medium: DMEM/F12, 20% Knockout Serum Replacement,Table 1
Primers used in the study.
Gene symbol Fwd and Rvs primers (5′-3′) PCR product (bp)
SeV GGATCACTAGGTGATATCGAGC
ACCAGACAAGAGTTTAAGAGATATGTATC
181
RPS18S TTAAGGGTGTGGGCCGAAGA
GGGATCTTGTACTGGCGTGGA
1421% MEM Non-Essential Amino Acid Solution, 0.1 mM β-
mercaptoethanol, 0.5% Pen/Strep, 10 ng/ml bFGF and supplemented
with 50 μg/ml Ascorbic acid. The colonies with an ES-like appearance
were manually isolated based on morphology between Day 21 to Day
27 post-transduction and cultured as iPSCs thereafter. Human iPSC cul-
tures were maintained on plates coated with Matrigel (BD Biosciences)
in mTESR-1 medium (Stem Cell Technologies) following the
manufacturer's instruction (Fig. 1A). All cells were cultured at 37 °C in
humidiﬁed atmosphere containing 5% CO2.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was isolated from cultured cells with RNeasy Micro Kit
(Qiagen) and reverse transcribed corresponding to SuperScript III Re-
verse Transcriptase protocol (Thermo Fisher Scientiﬁc). The RT-PCR re-
action was performed using GoTaq Hot Start Green Master Mix
(Promega). To conﬁrm the transgene-free status of the iPSC lines, SeV
speciﬁc primers were used described in CytoTune®-iPS 2.0 Sendai
Reprogramming Kit protocol (Thermo Fisher Scientiﬁc; Table 1).
In vitro spontaneous differentiation
The iPSCs were harvested according to the mTeSR-1 kit protocol
(StemCell Technologies) and the cell clumpswere plated on lowattach-
ment dishes in mTeSR medium. Five days later the embryoid bodies
(EBs) that had formed were plated on 24-well plates containing cover
slips (3–4 EBs/well), covered with 0.1% gelatin in differentiation medi-
um: DMEM, 20% FBS, 1% MEM Non-Essential Amino Acid Solution,
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83Z. Táncos et al. / Stem Cell Research 17 (2016) 81–830.1mM β-mercaptoethanol, 1% Pen/Strep. Themediumwas changed in
every second day hereafter. The cells were ﬁxed on Day 14 of differenti-
ation with 4% PFA for ICC staining speciﬁc for the 3 germ layers.
Immunocytochemistry (ICC)
The expression of speciﬁc pluripotency and germ layer markers
were analysed using conventional ICC staining. Cells were ﬁxed in 4%
PFA (20 min, RT), permeabilized with 0.1% Triton X-100 (5 min, RT)
and blocked in 1% bovine serum albumin (1 h, RT). The cells were incu-
bated with primary antibodies (overnight at 4 °C) and visualized with
secondary antibodies. For nuclei counterstaining 0.2 μg/ml DAPI
(20 min, RT) was used. The antibodies and applied dilutions are listed
in Table 2. The cells were observed under ﬂuorescent microscope
equipped with 3D imaging module, (Axio Imager system with
ApoTome; Carl Zeiss) controlled by AxioVision 4.8.1 microscope soft-
ware (Carl Zeiss).
Alkaline phosphatase (AP) staining
For detecting Alkaline phosphatase activity the 4% PFA ﬁxed cells
(20 min, RT) were stained AP solution (29.7 mM TRIS base; 6 mMma-
leic acid, pH 8.5–9.0; with 0.08% MgCl2, 10.8 mM Naphtol-As MX Phos-
phate; 23 μM Fast Red TR Salt; all from Sigma Aldrich) for 30 min (RT).
Samples were observed with Axio Imager system (Carl Zeiss).
Karyotyping
Cells were treated with KaryoMAX® Colcemid™ Solution
(Thermo Fisher Scientiﬁc) and processed with standard methods.
Standard Giemsa-banded karyotype was performed by Istenhegyi
GeneDiagnostic Center, Budapest (Hungary) and a minimum of 20
metaphases were analysed. The chromosomes were classiﬁed accord-
ing to the International System for Human Cytogenetic Nomenclature
(ISCN).
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